USAS BUILDING (02671) issued a profit warning, expecting a mid-term consolidated net profit of approximately 9.9 million yuan, a decrease of about 84.2% compared to the same period last year.
Mei Lian Holdings (02671) announced that the Group expects to achieve a consolidated net profit of approximately RMB 9.9 million for the six months ending June 30, 2026, a decrease of approximately RMB 52.7 million or about 84.2% compared to the consolidated net profit of approximately RMB 62.6 million for the six months ending June 30, 2025.
USAS BUILDING (02671) announced that the group expects to achieve a comprehensive net profit of approximately RMB 9.9 million for the six months ending June 30, 2026, a decrease of approximately RMB 52.7 million or about 84.2% compared to the comprehensive net profit of approximately RMB 62.6 million for the six months ending June 30, 2025.
The Board believes that the decline in the group's financial performance is primarily due to a reduction in revenue from prefabricated steel structure building subcontracting services, which has been largely affected by fluctuations in major client order cycles; and the delay in the commencement of new contracts and deferred revenue recognition. The contracts for new orders signed by the group in 2026 were finalized relatively late, with project commencement and delivery progress primarily concentrated in the second half of the year, leading to a total gross profit reduction of approximately RMB 83.7 million for the six months ending June 30, 2026.
Related Articles

China Resources Double-Crane Pharmaceutical (600062.SH): Lidocaine Hydrochloride Gel has obtained a drug registration certificate.

CHINA POWER (02380) plans to sell a 24.8726% stake in Qiyuan Xindongli to Contemporary Amperex Technology for 2.2557 billion yuan.

EASY SMART GP (02442): The controlling shareholder, Tianfu International, transfers 25% of its shares to TC in exchange for a 45.88% equity stake in TC's subsidiary.
China Resources Double-Crane Pharmaceutical (600062.SH): Lidocaine Hydrochloride Gel has obtained a drug registration certificate.

CHINA POWER (02380) plans to sell a 24.8726% stake in Qiyuan Xindongli to Contemporary Amperex Technology for 2.2557 billion yuan.

EASY SMART GP (02442): The controlling shareholder, Tianfu International, transfers 25% of its shares to TC in exchange for a 45.88% equity stake in TC's subsidiary.

RECOMMEND





